Sibelium

Flunarizine Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.

Molecular Formula: C₂₆H₂₆F₂N₂

InChI: InChI=1/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+

InChIKey: InChIKey=SMANXXCATUTDDT-QPJJXVBHBH
SMILES: C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F

Names:
    EINECS 257-937-5
    Flunarizina [INN-Spanish]
    flunarizine
    Flunarizinum [INN-Latin]
    Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, (E)-
    Sibelium
    (E)-1-(Bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)piperazine
    1-[bis(4-fluorophenyl)methyl]-4-cinnamyl-piperazine
    30484-77-6
    52468-60-7

Registries:
    PubChem CID 941361
    PubChem ID 181267